Cite
Gli1 + Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target.
MLA
Schneider, Rebekka K., et al. “Gli1 + Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target.” Cell Stem Cell, vol. 23, no. 2, Aug. 2018, pp. 308–09. EBSCOhost, https://doi.org/10.1016/j.stem.2018.07.006.
APA
Schneider, R. K., Mullally, A., Dugourd, A., Peisker, F., Hoogenboezem, R., Van Strien, P. M. H., Bindels, E. M., Heckl, D., Büsche, G., Fleck, D., Müller-Newen, G., Wongboonsin, J., Ventura Ferreira, M., Puelles, V. G., Saez-Rodriguez, J., Ebert, B. L., Humphreys, B. D., & Kramann, R. (2018). Gli1 + Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target. Cell Stem Cell, 23(2), 308–309. https://doi.org/10.1016/j.stem.2018.07.006
Chicago
Schneider, Rebekka K, Ann Mullally, Aurelien Dugourd, Fabian Peisker, Remco Hoogenboezem, Paulina M H Van Strien, Eric M Bindels, et al. 2018. “Gli1 + Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target.” Cell Stem Cell 23 (2): 308–9. doi:10.1016/j.stem.2018.07.006.